Literature DB >> 25010013

Fibronectin fragments and the cleaving enzyme ADAM-8 in the degenerative human intervertebral disc.

Nancy Ruel1, Dessislava Z Markova, Sherrill L Adams, Carla Scanzello, Gabriella Cs-Szabo, David Gerard, Peng Shi, D Greg Anderson, Marc Zack, Howard S An, Di Chen, Yejia Zhang.   

Abstract

STUDY
DESIGN: The presence of fibronectin fragments (FN-fs) and the cleaving enzyme, A disintegrin and metalloproteinase domain-containing protein (ADAM)-8 were examined in human intervertebral disc (IVD) tissue in vitro.
OBJECTIVE: To investigate the presence and pathophysiological concentration of FN-fs and their cleaving enzyme, ADAM-8, in the human IVD tissue. SUMMARY OF BACKGROUND DATA: The 29-kDa FN-f has been shown to result in extracellular matrix loss in rabbit IVDs. However, the concentration of this biologically active fragment in the degenerative human IVD tissue has previously not been determined. Furthermore, it is critical to identify the enzyme(s) responsible for FN cleavage in the IVD.
METHODS: Human degenerative IVD tissues were removed during spinal surgery. A normal seeming young adult and an infant human cadaveric sample were obtained as controls. Soluble proteins were extracted, and analyzed by Western blotting using antibodies specific for the human FN neoepitope VRAA²⁷¹. A purified 29-kDa FN-f was used to allow estimation of the concentration of FN-fs in the tissues. ADAM-8, a FN-cleaving enzyme, was analyzed by Western blotting and immunostaining.
RESULTS: All adult IVD tissues contain many FN-f species, but these species were absent from the infant disc tissue. Moderately degenerative discs contained the highest amount of FN-fs; the concentration was estimated to be in the nanomolar range per gram of tissue. ADAM-8, known to cleave FN resulting in the VRAA²⁷¹ neoepitope, was present in the human disc. ADAM-8 primarily localized in the pericellular matrix of the nucleus pulposus tissue, as determined by immunostaining.
CONCLUSION: This is the first report that N-terminal FN-fs are consistently present in IVD tissues from adult subjects. The pathophysiological concentration of these fragments is estimated to be at nanomolar range per gram of IVD tissue. Furthermore, ADAM-8, known to cleave FN, is present at the pericellular matrix of disc cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25010013      PMCID: PMC4229950          DOI: 10.1097/BRS.0000000000000397

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  20 in total

1.  Fibronectin matrix composition and organization can regulate cell migration during amphibian development.

Authors:  T Darribère; J E Schwarzbauer
Journal:  Mech Dev       Date:  2000-04       Impact factor: 1.882

Review 2.  Fibronectin at a glance.

Authors:  Roumen Pankov; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

3.  Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain.

Authors:  A Garcia-Pardo; E Pearlstein; B Frangione
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

4.  Magnetic resonance classification of lumbar intervertebral disc degeneration.

Authors:  C W Pfirrmann; A Metzdorf; M Zanetti; J Hodler; N Boos
Journal:  Spine (Phila Pa 1976)       Date:  2001-09-01       Impact factor: 3.468

5.  Detrimental role for human high temperature requirement serine protease A1 (HTRA1) in the pathogenesis of intervertebral disc (IVD) degeneration.

Authors:  André N Tiaden; Marina Klawitter; Vanda Lux; Ali Mirsaidi; Gregor Bahrenberg; Stephan Glanz; Lilian Quero; Thomas Liebscher; Karin Wuertz; Michael Ehrmann; Peter J Richards
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

6.  Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment.

Authors:  Takefumi Gemba; Jean Valbracht; Saifeddin Alsalameh; Martin Lotz
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

7.  A fibronectin fragment stimulates intervertebral disc degeneration in vivo.

Authors:  D Greg Anderson; Xudong Li; Tony Tannoury; Gina Beck; Gary Balian
Journal:  Spine (Phila Pa 1976)       Date:  2003-10-15       Impact factor: 3.468

8.  Functional analysis of fibronectin isoforms in chondrogenesis: Full-length recombinant mesenchymal fibronectin reduces spreading and promotes condensation and chondrogenesis of limb mesenchymal cells.

Authors:  Denise G White; Howard P Hershey; Jessica J Moss; Heather Daniels; Rocky S Tuan; Vickie D Bennett
Journal:  Differentiation       Date:  2003-06       Impact factor: 3.880

9.  Chick cartilage fibronectin differs in structure from the fibronectin in limb mesenchyme.

Authors:  D G White; J W Hall; D W Brandli; A L Gehris; V D Bennett
Journal:  Exp Cell Res       Date:  1996-05-01       Impact factor: 3.905

10.  Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.

Authors:  John H Peters; Steven Carsons; Mika Yoshida; Fred Ko; Skye McDougall; Grace A Loredo; Theodore J Hahn
Journal:  Arthritis Res Ther       Date:  2003-09-08       Impact factor: 5.156

View more
  12 in total

1.  Intervertebral Disc Degeneration in a Percutaneous Mouse Tail Injury Model.

Authors:  Zuozhen Tian; Xiaoyuan Ma; Miersalijiang Yasen; Robert L Mauck; Ling Qin; Frances S Shofer; Lachlan J Smith; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Am J Phys Med Rehabil       Date:  2018-03       Impact factor: 2.159

Review 2.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

3.  Influence of Genetic Background and Sex on Gene Expression in the Mouse (Mus musculus) Tail in a Model of Intervertebral Disc Injury.

Authors:  Julie M Brent; Zuozhen Tian; Frances S Shofer; John T Martin; Lutian Yao; Christian Acharte; Youhai H Chen; Ling Qin; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Comp Med       Date:  2020-03-10       Impact factor: 0.982

Review 4.  Discovery of the drivers of inflammation induced chronic low back pain: from bacteria to diabetes.

Authors:  Deborah J Gorth; Irving M Shapiro; Makarand V Risbud
Journal:  Discov Med       Date:  2015-10       Impact factor: 2.970

5.  Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs.

Authors:  Emerson Krock; J Brooke Currie; Michael H Weber; Jean A Ouellet; Laura S Stone; Derek H Rosenzweig; Lisbet Haglund
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

6.  Biomarkers in the Degenerative Human Intervertebral Disc Tissue and Blood.

Authors:  Yejia Zhang; Lutian Yao; Keith M Robinson; Timothy R Dillingham
Journal:  Am J Phys Med Rehabil       Date:  2021-12-27       Impact factor: 3.412

7.  Matrisome Profiling During Intervertebral Disc Development And Ageing.

Authors:  Joana Caldeira; Cátia Santa; Hugo Osório; Maria Molinos; Bruno Manadas; Raquel Gonçalves; Mário Barbosa
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

8.  Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix.

Authors:  T Kryza; C Parent; J Pardessus; A Petit; J Burlaud-Gaillard; P Reverdiau; S Iochmann; V Labas; Y Courty; N Heuzé-Vourc'h
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

9.  TNFAIP8 family gene expressions in the mouse tail intervertebral disc injury model.

Authors:  Zuozhen Tian; Frances S Shofer; Lutian Yao; Honghong Sun; Hongtao Zhang; Ling Qin; Youhai H Chen; Yejia Zhang
Journal:  JOR Spine       Date:  2020-06-19

10.  The Involvement of Protease Nexin-1 (PN1) in the Pathogenesis of Intervertebral Disc (IVD) Degeneration.

Authors:  Xinghuo Wu; Wei Liu; Zhenfeng Duan; Yong Gao; Shuai Li; Kun Wang; Yu Song; Zengwu Shao; Shuhua Yang; Cao Yang
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.